Digital and mobile health technologies offer promising solutions for smoking detection and cessation. This scoping review examines the current state of research and development in this field, ...

In the absence of high-quality evidence and guidelines, some practitioners have attempted to use established smoking cessation strategies ‘off-label’ for vaping cessation with unclear effect. The aim ...

Achieve Life Sciences Prices $45 Mln Offering To Advance Cytisinicline For Smoking Cessation June 27, 2025 — 12:30 pm EDT Written by RTTNews.com for RTTNews -> ...

The group and individual interventions were not cost-effective at conventional thresholds. Conclusions Enhancing motivational interviewing with additional behaviour change techniques was not effective ...

In June 2025, the company submitted its New Drug Application to the FDA for cytisinicline as a treatment of nicotine dependence for smoking cessation in adults, based on two successfully completed ...

MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 - A Drug Candidate Pending Acquisition - To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects ...

MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 – A Drug Candidate Pending Acquisition – To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects ...

MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 – A Drug Candidate Pending Acquisition – To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects ...

MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 – A Drug Candidate Pending Acquisition – To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects ...

MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 – A Drug Candidate Pending Acquisition – To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects ...